产品名称
MILLIPLEX® Human Neuroscience Panel, Configurable Human Neuroscience 6-Plex Panel 1
Quality Level
species reactivity
human
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
assay range
accuracy: 107%
(DJ1), accuracy: 108%
(a-Synuclein), accuracy: 123%
(TG2), standard curve range: 12-50,000 pg/mL
(GFAP), standard curve range: 15-60,000 pg/mL
(NSE), standard curve range: 20-80,000 pg/mL
(UCHL1), standard curve range: 244-1,000,000 pg/mL
(alpha-synuclein), standard curve range: 61-250,000 pg/mL
(DJ1), standard curve range: 61-250,000 pg/mL
(TG2)
technique(s)
multiplexing: suitable
input
cell culture supernatant
cerebrospinal fluid(s) (CSF)
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: α-Synuclein, DJ1/PARK7, Glial fibrillary acidic protein (GFAP), Neuron specific enolase (NSE), Transglutaminase 2 (TGM2), Ubiquitin carboxyl-terminal esterase L1 (UCHL1/PARK5).
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Comprehensive Neurological Assessment: Simultaneously quantify six critical biomarkers spanning neuronal damage, glial activation, and protein aggregation pathways, providing complete neurological dysfunction profiling in cerebrospinal fluid samples.
- Parkinson′s Disease Research Focus: Leverage specialized biomarkers including α-synuclein and DJ1/PARK7 that are directly implicated in Parkinson′s pathology, enabling targeted research into movement disorders and synucleinopathies.
- CSF-Optimized Performance: Specifically designed and verified for cerebrospinal fluid analysis, ensuring accurate quantification of brain-derived biomarkers in this challenging but clinically relevant sample matrix.
- Cross-Condition Biomarker Power: Utilize markers relevant to traumatic brain injury, neurodegenerative diseases, and neuroinflammation, maximizing research versatility across diverse neurological conditions and study designs.
- Configurable Panel Flexibility: Design your ideal research solution by selecting any combination of the 6 analytes, creating tailored assays that perfectly align with your specific neurological research objectives.
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
法规信息
此项目有
相关内容
了解如何结合MILLIPLEX®多重和单分子计数(SMC®)高灵敏度蛋白免疫测定技术，检测人脑脊液、血浆和血清样本中的阿尔茨海默病(AD)生物标志物，开展神经科学深度研究。
Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.
Learn how multiplex detection of Alzheimer’s disease biomarkers, using the MILLIPLEX® Human Amyloid Beta and Tau Magnetic Bead Panel, allows for a different perspective on neurodegenerative disease research.